Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast Cancer

Cancer Research

Volumn 64, Issue 8, 2004, Pages 2712-2716

  Huang, Yan ^a   Wang, Sophie ^a   Kelly, Thomas ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEPRASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER INVASION; CARCINOGENICITY; CELL GROWTH; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SERINE ENDOPEPTIDASES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 15944389319     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3184     Document Type: Article

References (32)

1. Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 1994;91:5657-61.
2. Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive and microinvasive ductal carcinoma cells of human breast cancers. Mod Pathol 1998;11:855-63.
3. Aoyama A, Chen W-T. A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci USA 1990;87:8296-300.
4. Kelly T. Evaluation of seprase activity. Clin Exp Metastasis 1999;17:57-62.
5. Monsky WL, Lin C-Y, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized to invadopodia of human malignant melanoma cells. Cancer Res 1994;54:5702-10.
6. Kelly T, Mueller SC, Yeh Y, Chen W-T. Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J Cell Physiol 1994;158:299-308.
7. Chen W-T, Kelly T. Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 2003;22:259-69.
8. Nakahara H, Nomizu M, Akiyama SK, Yamada Y, Yeh Y, Chen W-T. A mechanism for regulation of melanoma invasion. J Biol Chem 1996;271:27221-4.
9. Kelly T, Yan Y, Osborne RL, et al. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998;16:501-12.
10. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res 1993;53:3159-64.
11. Goodman J, Rozypal TL, Kelly T. Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells. Clin Exp Metastasis 2003;20:459-70.
12. Cheng JD, Dunbrack RL, Jr., Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 2002;62:4767-72.
13. Chen W-T, Kelly T, Ghersi G. DPPIV, seprase and related serine peptidases in multiple cellular functions. In: Zucker S, and Chen W-T, editors. Cell surface proteases, vol, 54. San Diego, CA: Academic Press, 2003. p. 207-32.
14. Goldstein LA, Ghersi G, Pineiro-Sanchez ML, et al. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta 1997;1361:11-9.
15. Bermpohl F, Loster K, Reutter W, Baum O. Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens. FEBS Lett 1998;428:152-6.
16. Pineiro-Sanchez M, Goldstein LA, Dodt J, Howard L, Yeh Y, Chen W-T. Identification of the 170 kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 1997;272:7595-601.
17. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
18. Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RD, Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 2002;62:3722-8.
19. Pieters R, Huismans DR, Leyva A, Veerman AJ. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett 1988;41:323-32.
20. Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci USA 1988;85:3110-4.
21. Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 1990;87:7235-9.
22. Thompson EW, Paik S, Brunner N, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992;150:534-44.
23. Yaccoby S, Johnson CL, Mahaffey SC, Wezeman MJ, Barlogie B, Epstein J. Antimyeloma efficacy of thalidomide in the SCID-hu model. Blood 2002;100:4162-8.
24. Aimes RT, Zijlstra A, Hooper JD, et al. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost 2003;89:561-72.
25. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA, Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: Role of its inducible receptors. Regul Pept 1998;75-76:231-8.
26. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998;83:187-95.
27. Ghersi G, Chen W, Lee EW, Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 2001;22:453-8.
28. Zukowska Z, Grant DS, Lee EW. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003;13:86-92.
29. Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. J Intl Cancer 2001;95:67-72.
30. Okada K, Chen WT, Iwasa S, Jin X, Yamane T, Ooi A, Mitsumata M. Seprase, a membrane-type serine protease, has different expression patterns in intestinal and diffuse-type gastric cancer. Oncology 2003;65:363-70.
31. Tanswell P, Garin-Chesa P, Rettig WJ, et al. Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. Brit J Clin Pharmacol 2001;51:177-80.
32. Scott AM, Wiseman G, Welt S, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res 2003;9:1639-47.